🧫b.next Ships 100th Synthetic Cell Kit, Aims for Cytosol Standardization
b.next's Cytosol Kits Could Democratize Synthetic Cell Research
TL;DR
b.next, a synthetic cell factory, has shipped its 100th kit, aiming to standardize Cytosol production for synthetic cell research. The company's open protocols and materials could reduce costs and increase accessibility for researchers worldwide.
b.next, a synthetic cell factory, has shipped its 100th kit, aiming to standardize Cytosol production for synthetic cell research. The company's open protocols and materials could reduce costs and increase accessibility for researchers worldwide. b.next's work on open PURE systems and Cytosol kits has supported over 20 labs and enabled high-throughput screening and optimization. The company's efforts to develop digital and automation tools around Cytosol could further accelerate research and innovation in synthetic biology. This is a big deal for synthetic cell researchers looking to streamline their workflows and reduce costs.
Key Points
b.next has shipped its 100th synthetic cell kit, supporting over 20 labs worldwide.
The company's open PURE system includes 36 proteins, 31 small molecules, and 43 tRNA, with ribosomes.
b.next developed and optimized open protocols for producing all PURE components in mid-2025.
The company hosted its first PURE workshop with 8 graduate students and post-docs from major labs in mid-2025.
b.next is building digital and automation tools for design, analysis, and AI-driven engineering of synthetic cells.
Why It Matters
If you're working on synthetic cell research, b.next's Cytosol kits could significantly reduce costs and streamline your workflows. The open protocols and materials could enable more labs to participate in cutting-edge research, potentially accelerating breakthroughs in synthetic biology. Researchers at labs like Nucleus are already seeing the benefits of standardized Cytosol production, with faster and more reliable results.
Frequently Asked Questions
Why does this matter?
If you're working on synthetic cell research, b.next's Cytosol kits could significantly reduce costs and streamline your workflows. The open protocols and materials could enable more labs to participate in cutting-edge research, potentially accelerating breakthroughs in synthetic biology. Researchers at labs like Nucleus are already seeing the benefits of standardized Cytosol production, with faster and more reliable results.
What happened?
b.next, a synthetic cell factory, has shipped its 100th kit, aiming to standardize Cytosol production for synthetic cell research. The company's open protocols and materials could reduce costs and increase accessibility for researchers worldwide.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,472 builders reading daily.